Journal of Materials Science: Materials in Medicine (Sep 2021)

Application of plasma polymerized pyrrole nanoparticles to prevent or reduce de-differentiation of adult rat ventricular cardiomyocytes

  • Omar Uribe-Juárez,
  • Rafael Godínez,
  • Juan Morales-Corona,
  • Myrian Velasco,
  • Roberto Olayo-Valles,
  • M. C. Acosta-García,
  • E. J. Alvarado,
  • Luis Miguel-Alavez,
  • Oscar-J. Carrillo-González,
  • María G. Flores-Sánchez,
  • Roberto Olayo

DOI
https://doi.org/10.1007/s10856-021-06595-7
Journal volume & issue
Vol. 32, no. 9
pp. 1 – 10

Abstract

Read online

Abstract Cardiovascular diseases are the leading cause of death in the world, cell therapies have been shown to recover cardiac function in animal models. Biomaterials used as scaffolds can solve some of the problems that cell therapies currently have, plasma polymerized pyrrole (PPPy) is a biomaterial that has been shown to promote cell adhesion and survival. The present research aimed to study PPPy nanoparticles (PPPyN) interaction with adult rat ventricular cardiomyocytes (ARVC), to explore whether PPPyN could be employed as a nanoscaffold and develop cardiac microtissues. PPPyN with a mean diameter of 330 nm were obtained, the infrared spectrum showed that some pyrrole rings are fragmented and that some fragments of the ring can be dehydrogenated during plasma synthesis, it also showed the presence of amino groups in the structure of PPPyN. PPPyN had a significant impact on the ARVC´s shape, delaying dedifferentiation, necrosis, and apoptosis processes, moreover, the cardiomyocytes formed cell aggregates up to 1.12 mm2 with some aligned cardiomyocytes and generated fibers on its surface similar to cardiac extracellular matrix. PPPyN served as a scaffold for adult ARVC. Our results indicate that PPPyN-scaffold is a biomaterial that could have potential application in cardiac cell therapy (CCT).